Inventor · disambiguated record
Joshua Clayton
Also filed as: CLAYTON JOSHUA · CLAYTON JOSHUA R · CLAYTON JOSHUA RYAN
26 granted patents·14 pending applications·114 citations·filing 2003–2025
95Inventor score
Top patents by PatentIndex Score
40 records- 0193US7485722B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2007·Granted Feb 3, 2009·29 cites·13 claims
- 0290US9556153B1JAK1 inhibitorsLILLY CO ELI·Filed 2016·Granted Jan 31, 2017·9 cites·28 claims
- 0388US7799792B2Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841ASTRAZENECA AB·Filed 2008·Granted Sep 21, 2010·11 cites·14 claims
- 0486US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 0585US8309744B2Prostaglandin synthesis and intermediates for use thereinALBERICO DINO·Filed 2011·Granted Nov 13, 2012·4 cites·6 claims
- 0683US7928252B2Prostaglandin synthesis and intermediates for use thereinALPHORA RES INC·Filed 2008·Granted Apr 19, 2011·3 cites·12 claims
- 0783US7666879B2Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitorsLILLY CO ELI·Filed 2006·Granted Feb 23, 2010·10 cites·7 claims
- 0882US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 0981US8377940B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·4 cites·13 claims
- 1081US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 1179US7897600B2Amino pyrazole compoundLILLY CO ELI·Filed 2009·Granted Mar 1, 2011·6 cites·9 claims
- 1277US12404298B2Glucocorticoid receptor agonistsLILLY CO ELI·Filed 2023·Granted Sep 2, 2025·0 cites·25 claims
- 1375US8513441B2Prostaglandin synthesis and intermediates for use thereinALBERICO DINO·Filed 2009·Granted Aug 20, 2013·1 cites·4 claims
- 1475US8058425B2Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Granted Nov 15, 2011·5 cites·8 claims
- 1573US11787834B2Glucocorticoid receptor agonistsLILLY CO ELI·Filed 2022·Granted Oct 17, 2023·0 cites·7 claims
- 1673US2025353874A1Glucocorticoid receptor agonistsLILLY CO ELI·Filed 2025·Application pending·0 cites
- 1771US8436002B2AKT inhibitorsBEIGHT DOUGLAS WADE·Filed 2010·Granted May 7, 2013·3 cites·10 claims
- 1869US7405305B2Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitorsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·6 cites·9 claims
- 1964US10323019B2Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsLILLY CO ELI·Filed 2017·Granted Jun 18, 2019·0 cites·18 claims
- 2062US8377939B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·0 cites·4 claims
- 2162US2024173425A1Human cd33 antibodies and glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2261US2013338379A1Prostaglandin synthesis and intermediates for use thereinALPHORA RES INC·Filed 2013·Application pending·0 cites
- 2360US10344018B2Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsLILLY CO ELI·Filed 2019·Granted Jul 9, 2019·0 cites·9 claims
- 2460US7790717B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2009·Granted Sep 7, 2010·0 cites·2 claims
- 2559US2013072695A1Prostaglandin synthesis and intermediates for use thereinALPHORA RES INC·Filed 2012·Application pending·0 cites
- 2657US2010280082A1Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as PotentiatorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2757US2024082414A1Human tumor necrosis factor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2856US2024100176A1Human interleukin-4 receptor alpha antibody glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2956US2024228511A1Substituted fused azines as kras g12d inhibitorsLILLY CO ELI·Filed 2022·Application pending·0 cites
- 3054US9403864B2Process for the synthesis of carbonucleoside and intermediates for use thereinALBERICO DINO·Filed 2011·Granted Aug 2, 2016·0 cites·22 claims
- 3154US2011112312A1Prostaglandin synthesis and intermediates for use thereinALPHORA RES INC·Filed 2011·Application pending·0 cites
- 3252US9062050B2Inhibitor of JAK1 and JAK2LILLY CO ELI·Filed 2013·Granted Jun 23, 2015·0 cites·6 claims
- 3349US2022177426A1Process for preparing alpha-carboxamide pyrrolidine derivativesBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 3447US2011053953A1AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613SLASSI ABDELMALIK·Filed 2008·Application pending·0 cites
- 3547US2011294792A1Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Application pending·0 cites
- 3646US8658792B2Carbanucleoside synthesis and novel intermediate compounds useful thereinALBERICO DINO·Filed 2011·Granted Feb 25, 2014·0 cites·9 claims
- 3745US7816354B2Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Oct 19, 2010·0 cites·6 claims
- 3845US2009149505A1Metabotropic Glutamate Receptor-Potentiating IsoindolonesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3943US2011166155A1Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor PotentiatorsVAN WAGENEN BRADFORD·Filed 2011·Application pending·0 cites
- 4037US8153638B2Metabotropic glutamate-receptor-potentiating isoindolonesVAN WAGENEN BRADFORD·Filed 2010·Granted Apr 10, 2012·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Joshua Clayton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →